Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Cerebral Venous Sinus Thrombosis as a Rare Complication of Systemic Lupus Erythematosus: Subgroup Analysis of the VENOST Study.

Duman T, Demirci S, Uluduz D, Kozak HH, Demir S, Mısırlı CH, Küçükoğlu H, Çınar N, Domaç FM, Öztürk Ş; VENOST Study Group, Sungur MA, Yayla V, Karahan AY, Afşar N, Göksu EÖ, Aytaç E, Yeşilot N, İnce B, Yalın OÖ, Oruç S, Senol MG, Yılmaz A, Gökçe M, Küsbeci ÖY, Uzuner G, Batur Çağlayan HZ, Açıkgöz M, Kurucu H, Ozdag F, Ekmekci H, Çabalar M, Yurekli VA, Güneş T, Genç H, Utku U, Şahin Ş, Tokuc FEU, Uzuner N, Bektaş H, Kablan Y, Göksel BK, Milanlıoğlu A, Örken DN, Aluclu U, Midi İ, Çolakoğlu S, Tüfekçi A, Bakar M, Nazlıel B, Taşçılar N, Göksan B.

J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104372. doi: 10.1016/j.jstrokecerebrovasdis.2019.104372. Epub 2019 Sep 24.

PMID:
31562041
2.

Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.

Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators.

N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959.

PMID:
31091372
3.

LDL Subclasses in Ischemic Stroke: A Risk Factor?

Kayran Y, Yayla V, Çabalar M, Bajrami A, Karamanli Y, Gedikbaşi A, Tanriverdİ Z.

Noro Psikiyatr Ars. 2019 Mar;56(1):13-17. doi: 10.5152/npa.2017.19393. Epub 2018 Jul 5.

4.

Behçet's disease as a causative factor of cerebral venous sinus thrombosis: subgroup analysis of data from the VENOST study.

Uluduz D, Midi I, Duman T, Colakoglu S, Tüfekci A, Bakar M, Nazliel B, Tascilar N, Goksan B, Sungur MA, Kozak HH, Demir S, Misirli CH, Kucukoglu H, Cinar N, Domac FM, Ozturk S, Yayla V, Karahan AY, Afsar N, Goksu EO, Mengulluoglu N, Aytac E, Yesilot N, Ince B, Yalin OO, Oruc S, Demirci S, Senol MG, Yilmaz A, Gokce M, Yilmaz Kusbeci Ö, Uzuner G, Batur Caglayan HZ, Acikgoz M, Zeydan B, Ozdag F, Baybas S, Ekmekci H, Cabalar M, Yaman M, Yurekli VA, Tekeli H, Genc H, Utku U, Ucan Tokuc FE, Uzuner N, Bektas H, Kablan Y, Goksel BK, Milanlioglu A, Necioglu Orken D, Aluclu U.

Rheumatology (Oxford). 2019 Apr 1;58(4):600-608. doi: 10.1093/rheumatology/key153.

PMID:
29992235
5.

Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.

Langhorne P, O'Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, Mathur N, Turner M, MacLeod MJ, Lopez-Jaramillo P, Damasceno A, Hankey GJ, Dans AL, Elsayed A, Mondo C, Wasay M, Czlonkowska A, Weimar C, Yusufali AH, Hussain FA, Lisheng L, Diener HC, Ryglewicz D, Pogosova N, Iqbal R, Diaz R, Yusoff K, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Magazi D, Nilanont Y, Rosengren A, Oveisgharan S, Yusuf S; INTERSTROKE collaborators.

Lancet. 2018 May 19;391(10134):2019-2027. doi: 10.1016/S0140-6736(18)30802-X. Epub 2018 May 17.

PMID:
29864018
6.

Peripheral neuropathy in Tangier disease: A literature review and assessment.

Mercan M, Yayla V, Altinay S, Seyhan S.

J Peripher Nerv Syst. 2018 Jun;23(2):88-98. doi: 10.1111/jns.12265. Epub 2018 May 8. Review.

PMID:
29582519
7.

A database for screening and registering late onset Pompe disease in Turkey.

Gokyigit MC, Ekmekci H, Durmus H, Karlı N, Koseoglu E, Aysal F, Kotan D, Ali A, Koytak PK, Karasoy H, Yaman A, Sengun İS, Sayin R, Tiftikcioglu BI, Soysal A, Tutkavul K, Bayrak AO, Kısabay A, Elci MA, Yayla V, Yılmaz İA, Ozdamar SE, Erdogan C, Tasdemir N, Serdaroglu Oflazer P; Turkish Study Group for Late Onset Pompe Disease.

Neuromuscul Disord. 2018 Mar;28(3):262-267. doi: 10.1016/j.nmd.2017.12.008. Epub 2017 Dec 20.

PMID:
29395671
8.

Incidental Thrombotic Thrombocytopenic Purpura during Acute Ischemic Stroke and Thrombolytic Treatment.

Acır İ, Erdoğan HA, Yayla V, Taşdemir N, Çabalar M.

J Stroke Cerebrovasc Dis. 2018 May;27(5):1417-1419. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.032. Epub 2017 Nov 28.

PMID:
29196200
9.

Hormonal effect on the relationship between migraine and female sexual dysfunction.

Dogan VB, Dagdeviren H, Dirican A, Dirican AC, Tutar NK, Yayla VA, Cengiz H.

Neurol Sci. 2017 Sep;38(9):1651-1655. doi: 10.1007/s10072-017-3023-5. Epub 2017 Jun 28.

PMID:
28660561
10.

A Multicenter Study of 1144 Patients with Cerebral Venous Thrombosis: The VENOST Study.

Duman T, Uluduz D, Midi I, Bektas H, Kablan Y, Goksel BK, Milanlioglu A, Necioglu Orken D, Aluclu U; VENOST Study Group.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1848-1857. doi: 10.1016/j.jstrokecerebrovasdis.2017.04.020. Epub 2017 Jun 2.

PMID:
28583818
11.

[A rarely known headache: Airplane travel headache].

Azman F, Erkılınç B, Çabalar M, Çağırıcı S, Yayla V.

Agri. 2017 Jan;29(1):47-48. doi: 10.5505/agri.2015.79037. Turkish.

12.

The Role of Patent Foramen Ovale in Cryptogenic Stroke.

Şenadim S, Bozkurt D, Çabalar M, Bajrami A, Yayla V.

Noro Psikiyatr Ars. 2016 Mar;53(1):63-66. doi: 10.5152/npa.2015.10034. Epub 2016 Mar 1.

13.

Pazopanib induced unilateral posterior reversible encephalopathy syndrome.

Arslan BM, Bajrami A, Demir E, Cabalar M, Yayla V.

Ideggyogy Sz. 2017 Mar 30;70(3-4):140-144. doi: 10.18071/isz.70.0001.

PMID:
29870619
14.

The evaluation of the relationship between risk factors and prognosis in intracerebral hemorrhage patients.

Senadim S, Cabalar M, Yayla V, Bulut A.

Ideggyogy Sz. 2017 Jan 30;70(1-2):33-41. doi: 10.18071/isz.70.0033.

PMID:
29870191
15.

A case of thalamo-mesencephalon infarct presenting as transient global amnesia: do we overlook the diagnosis?

Dogan VB, Dogan GB, Turkmen U, Yayla VA.

Neurol Sci. 2017 May;38(5):909-911. doi: 10.1007/s10072-017-2818-8. Epub 2017 Jan 12. No abstract available.

PMID:
28083760
16.

Perineural dexmedetomidine effects on sciatic nerve in rat.

Yektaş A, Çabalar M, Sar M, Alagöl A, Çelik DS, Yayla V, Tolga D.

Braz J Anesthesiol. 2017 Jan - Feb;67(1):57-66. doi: 10.1016/j.bjane.2015.08.012. Epub 2016 Apr 28.

17.

MRI findings and cognitive functions in a small cohort of myotonic dystrophy type 1: Retrospective analyses.

Bajrami A, Azman F, Yayla V, Cagirici S, Keskinkiliç C, Sozer N.

Neuroradiol J. 2017 Feb;30(1):23-27. doi: 10.1177/1971400916678223. Epub 2016 Nov 11.

18.

[Perineural dexmedetomidine effects on sciatic nerve in rat].

Yektaş A, Çabalar M, Sar M, Alagöl A, Çelik DS, Yayla V, Tolga D.

Rev Bras Anestesiol. 2017 Jan - Feb;67(1):57-66. doi: 10.1016/j.bjan.2016.10.004. Epub 2016 Nov 3. Portuguese.

19.

A Rare Cause of Hearing Loss: Susac Syndrome.

Yurtsever B, Çabalar M, Kaya H, Tuğcu B, Yazıcı ZM, Yayla V.

J Int Adv Otol. 2015 Aug;11(2):167-9. doi: 10.5152/iao.2015.1002.

20.

A cross-sectional evaluation of home health service in patients with chronic neurologic diseases in a province of Turkey.

Senadim S, Cabalar M, Gedik H, Kasim AB, Bulut A, Yayla V, Erdogdu Z.

Acta Neurol Belg. 2016 Mar;116(1):65-72. doi: 10.1007/s13760-015-0509-x. Epub 2015 Jul 19.

PMID:
26189106

Supplemental Content

Loading ...
Support Center